{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:31:20Z","timestamp":1791729080170,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1716,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1038\/modpathol.2017.175","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T07:40:36Z","timestamp":1515742836000},"page":"705-717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity"],"prefix":"10.1016","volume":"31","author":[{"given":"Erica F","family":"Reinig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia T","family":"Greipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaaren K","family":"Reichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2017.175_bib1","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th Edition)","article-title":"Pure erythroid leukemia","author":"Arber","year":"2017"},{"key":"10.1038\/modpathol.2017.175_bib2","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.175_bib3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/MOH.0000000000000314","article-title":"Revisiting erythroleukemia","volume":"24","author":"Arber","year":"2017","journal-title":"Curr Opin Hematol"},{"key":"10.1038\/modpathol.2017.175_bib4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/10428194.2011.607526","article-title":"Clinicopathologic features and outcome of acute erythroid leukemia based on 2008 revised World Health Organization classification","volume":"53","author":"Liu","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/modpathol.2017.175_bib5","doi-asserted-by":"crossref","first-page":"e41485","DOI":"10.1371\/journal.pone.0041485","article-title":"Acute myeloid leukemia (AML) with erythroid predominance exhibits clinical and molecular characteristics that differ from other types of AML","volume":"7","author":"Zuo","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1038\/modpathol.2017.175_bib6","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/leu.2013.144","article-title":"Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics","volume":"27","author":"Grossmann","year":"2013","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2017.175_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1309\/AJCPRKYAT6EZQHC7","article-title":"Acute erythroleukemias, acute megakaryoblastic leukemias, and reactive mimics: a guide to a number of perplexing entities","volume":"144","author":"Wang","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2017.175_bib8","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1182\/blood-2009-09-243964","article-title":"Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification","volume":"115","author":"Hasserjian","year":"2010","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.175_bib9","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/modpathol.2016.118","article-title":"Acute erythroid leukemia with <20% bone marrow blasts is clinically and biologically similar to myelodysplastic syndrome with excess blasts","volume":"29","author":"Wang","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2017.175_bib10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ajh.24626","article-title":"Pure erythroid leukemia","volume":"92","author":"Wang","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1038\/modpathol.2017.175_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.humpath.2011.08.008","article-title":"Erythroid proliferations in myeloid neoplasms","volume":"43","author":"Wang","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2017.175_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/jclinpath-2014-202740","article-title":"How unique is pure erythroid leukaemia? A retrospective analysis of seven cases and review of the literature","volume":"68","author":"Wong","year":"2015","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2017.175_bib13","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3332\/ecancer.2017.712","article-title":"Study of clinical, haematological and cytogenetic profile of patients with acute erythroid leukaemia","volume":"11","author":"Linu","year":"2017","journal-title":"Ecancermedicalscience"},{"key":"10.1038\/modpathol.2017.175_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/modpathol.2010.194","article-title":"Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification","volume":"24","author":"Liu","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2017.175_bib15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/his.13207","article-title":"Acute leukaemia with a pure erythroid phenotype: under-recognized morphological and cytogenetic signatures associated universally with primary refractory disease and a dismal clinical outcome","volume":"71","author":"Park","year":"2017","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2017.175_bib16","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1182\/blood-2016-11-749903","article-title":"More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia","volume":"129","author":"Montalban-Bravo","year":"2017","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.175_bib17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/ajcp\/aqw033","article-title":"Pure erythroid leukemia and erythroblastic sarcoma evolving from chronic myeloid neoplasms","volume":"145","author":"Li","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2017.175_bib18","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.3324\/haematol.2011.043687","article-title":"Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells","volume":"96","author":"Bacher","year":"2011","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2017.175_bib19","first-page":"148","article-title":"Acute erythroid neoplastic proliferations. A biological study based on 62 patients","volume":"87","author":"Domingo-Claros","year":"2002","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2017.175_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cancergencyto.2005.05.006","article-title":"Cytogenetic study of 75 erythroleukemias","volume":"163","author":"Lessard","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1038\/modpathol.2017.175_bib21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0145-2126(01)00146-1","article-title":"Erythroleukemia: a comparison between the previous FAB approach and the WHO classification","volume":"26","author":"Park","year":"2002","journal-title":"Leuk Res"},{"key":"10.1038\/modpathol.2017.175_bib22","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4065\/83.7.776","article-title":"Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients","volume":"83","author":"Morice","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1038\/modpathol.2017.175_bib23","series-title":"ISCN 2016: An International System for Human Cytogenomic Nomenclature (2016)","author":"McGowan-Jordan","year":"2016"},{"key":"10.1038\/modpathol.2017.175_bib24","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/PAS.0b013e31825fa501","article-title":"alpha-Hemoglobin-stabilizing protein is a sensitive and specific marker of erythroid precursors","volume":"36","author":"Raess","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.175_bib25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/PAS.0b013e31821247a8","article-title":"CD71 is selectively and ubiquitously expressed at high levels in erythroid precursors of all maturation stages: a comparative immunochemical study with glycophorin A and hemoglobin A","volume":"35","author":"Dong","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.175_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/PAI.0000000000000139","article-title":"alpha-Hemoglobin-stabilizing protein: an effective marker for erythroid precursors in bone marrow biopsy specimens","volume":"24","author":"Yu","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/modpathol.2017.175_bib27","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/his.12101","article-title":"Ferritin H is a novel marker of early erythroid precursors and macrophages","volume":"62","author":"Wang","year":"2013","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2017.175_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1309\/AJCP0QFQ0FTSZCPW","article-title":"ALDH, CA I, and CD2AP: novel, diagnostically useful immunohistochemical markers to identify erythroid precursors in bone marrow biopsy specimens","volume":"137","author":"Rollins-Raval","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2017.175_bib29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.path.2013.08.006","article-title":"Erythroleukemia and its differential diagnosis","volume":"6","author":"Hasserjian","year":"2013","journal-title":"Surg Pathol Clin"},{"key":"10.1038\/modpathol.2017.175_bib30","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/modpathol.2016.206","article-title":"Immunohistochemistry for p53 is a useful tool to identify cases of acute myeloid leukemia with myelodysplasia-related changes that are TP53 mutated, have complex karyotype, and have poor prognosis","volume":"30","author":"Fernandez-Pol","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2017.175_bib31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/emph\/eot020","article-title":"Genome organization and the role of centromeres in evolution of the erythroleukaemia cell line HEL","volume":"2013","author":"Mackinnon","year":"2013","journal-title":"Evol Med Public Health"},{"key":"10.1038\/modpathol.2017.175_bib32","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/leu.2015.198","article-title":"Molecular characterization of acute erythroid leukemia (M6-AML) using targeted next-generation sequencing","volume":"30","author":"Cervera","year":"2016","journal-title":"Leukemia"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2017175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2017175","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222015046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222015046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/modpathol.2017.175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2017175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:48:53Z","timestamp":1760230133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222015046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0893395222015046"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2017.175","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2017.175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}